| Financial Year |
March 31 2023 |
| Monetary Funds |
389,174,762.53 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,447,097.70 |
| Accounts Receivable |
210,354,642.22 |
| Advances to Suppliers |
10,345,849.19 |
| Other Receivables |
2,226,833.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
217,891,483.32 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,711,290.29 |
| Total Current Assets |
839,797,218.47 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
376,812.55 |
| Fixed Assetes |
48,416,307.57 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
11,243,825.92 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,160,770.01 |
| Deferred Income Tax Assets |
18,065,052.17 |
| Other Non-Current Assets |
22,111,165.52 |
| Sub-Total of Non-Current Assets |
101,373,933.74 |
| Total Assets |
941,171,152.21 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
8,300,520.00 |
| Accounts Payable |
70,761,045.96 |
| Accounts Received In Advance |
42,000.00 |
| Employee Compensation Payable |
10,526,078.15 |
| Taxes Payable |
9,831,593.82 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,617,355.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
18,312,328.38 |
| Sub-Total of Current Liabilities |
280,556,175.34 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
628,892.71 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
13,167.10 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
642,059.81 |
| Total Liabilities |
281,198,235.15 |
| Paid-In Capital(Or Share Stock) |
207,642,172.00 |
| Capital Surplus |
192,398,461.25 |
| Surplus Reserve |
32,992,673.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
226,939,610.81 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
659,972,917.06 |
| Owner's Equity（Stockholder's Equity） |
659,972,917.06 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
941,171,152.21 |
